This study aimed to investigate the existence and molecular epidemiological characteristics of multidrug resistant
INTRODUCTION
Acinetobacter baumannii has recently emerged as a significant pathogen, with a surprisingly rapid acquisition of antibiotic resistance and fast proliferation within hospitals (Jiang et al., 2012) . Several studies have demonstrated that Multidrug-resistant A. baumannii (MDRAB) and extensive drug-resistant A. baumannii have caused significant challenges in clinical treatment (Munoz and Weinstein, 2008; Peleg et al., 2008; Doi et al., 2009) . Carbapenems, fluoroquinolones, aminoglycosides, sulbactam, and sulbatacm combinations are often used against A. baumannii. However, the number and incidence of MDRAB strains had increased considerably during the past decade. The current study examined the β-lactam, aminoglycoside, fluoroquinolones, and disinfectant-related resistance genes (qacE△1 gene) of MDRAB strains isolated from our hospital. In addition, the statistical distribution of the resistant strains was also investigated to analyze the resistance mechanisms and relationships among MDRAB strains from our hospital.
MATERIALS AND METHODS

Source of strain
Clinical isolates were isolated from the Microbiology Laboratory in our hospital using standard procedures. A total of 46 MDRAB isolates were collected from June 2010 to June 2011, of which 44 isolates were from the sputum, one from puncture fluid, and one *Corresponding author. E-mail: taianshupingzhao@163.com. Tel: +86 0538 6298370. from secretions.
Bacterial identification and antibiotic susceptibility determination
MDRAB is A. baumannii resistant to multiple antibiotics, often defined as three or more antimicrobials (aminoglycoside, ampicillinsulbactam, antipseudomonal carbapenem, antipseudomonal cephalosporin, fluoroquinolone). The bacteria were identified using WalkAway 96 PLUS NC31 composite panels. Antimicrobial susceptibility test was performed using the Kirby-Bauer disk diffusion method. Susceptibility testing was performed in accordance with Clinical and Laboratory Standards Institute Guidelines of 2011. Susceptibility was tested for the following antimicrobial agents: amikacin, ceftazidime, ceftriaxone, ciprofloxacin, cefepime, gentamicin, imipenem, levofloxacin, meropenem, piperacilin, cotrimoxazole, piperacilkin/tazobactam, tobramycin, cefoperazone / sulbactam, minocycline, and tigecycline. Susceptibility to polymyxin E was examined using ATB PSE strips. MH agar and susceptibility paper were both purchased from British Oxoid.
Resistance gene detection
Bacterial DNA was extracted using the boil extraction method and resistance gene detection was performed via polymerase chain reaction (PCR). Table 1 lists the pairs of oligonucleotide primers designed to target β-lactam resistance genes. The primers were designed according to previously published procedure Hu et al., 2008) . Sixteen (16) pairs of oligonucleotide primers (Table 2) were designed to target aminoglycosides, plasmidmediated fluoroquinolones, and disinfectant-related resistance genes. The primers were designed according to previously published procedure (Zhi et al., 2005; Wang et al., 2009; Yang et al., 2011; Chi et al., 2006; Turton et al., 2006) .
A number of positive gene PCR products were analyzed for nucleotide sequence by Shanghai Sunny Biotechnology Co., Ltd. The resulting sequence data were compared with the data from the GenBank database using BLAST at the National Center for Biotechnology Information Web site (http://www.ncbi.nlm.nih.gov/).
Homology analysis
Pulsed-field gel electrophoresis (PFGE) was performed following the protocol of Gautom with some modifications. The PFGE patterns were analyzed by computer-assisted program (Bio-Numerics software. Version 5.1, Appliedmaths, Inc.) and by manual or visual comparison of each band patterns. Band patterns were compared and classified as nondistinguishable and unrelated with 90% as the homology threshold.
RESULT
Antibiotic Resistance
The sensitivities of the 46 strains to 17 antimicrobials are presented in Table 3 .
PFGE
The PFGE patterns of the 46 MDRAB isolates were analyzed using computer-assisted program (BioNumerics software. Version 5.1, Appliedmaths, Inc.) and by manual or visual comparison of each band patterns. A 90% inter-linkage homology level between patterns was considered as the cutoff for defining close genetic relationship isolates. Isolates were categorized into 20 major groups and designated as Strains A to T based on the generated dendrogram ( Figure 1) . A total of nine isolates were categorized as, strain A (19.6%), eight as strain B (17.4%), and four as strain O (8.7%). The other types of strains only contained 1 or 2 isolates. All strains were found in the intensive care wards. The distribution of which is shown in Table 4 .
Detection of β-lactam resistance gene and sequencing results
Approximately 100% of the 46 MDRAB isolates carried β-lactam resistance genes. The numbers of isolates that carried a particular gene were as follows: 41 (89.1%) OXA23, 17 (37%) PER, 6 (13%) IMP, and 4 (8.7%) of both OXA23 and IMP-4 genes. Sequence analysis of PCR amplification products of the three OXA23 genepositive isolates showed 100% homology with JN207493. Four of the amplification products of the six IMPgene positive isolate showed that four isolates were 100% homologous to JN106667 and the rest only showed 99%. The sequence analysis of the PCR amplification products of 4 PER gene-positive isolates showed 99% homology with FE535600.
Detections of aminoglycoside and plasmid-mediated quinolone resistance genes as well as qacE△1 gene
The numbers of isolates among the 46 MDRAB isolates that carried a particular gene were as follows: 40 (87.0%), armA; 41 (89.1%), ant(3")-; 33 (71.7%), aac(3)-I; 2 (4.3%), aac(3)-II; 1 (2.2%), aac(6')-II; 1 (2.2%), aph(3')-VI; 41 (89.1%), AMES; 40 (87%), 16SrRNA methylase; and 43 (93.5%), qacE∆1. The aac(3)-III, aac(3)-IV, aac(6')-I, and ant(2")-I AMES genes were not detected. No rmtB16SrRNA methylase gene was detected. Plasmid-mediated fluoroquinolone resistance genes, namely, qnrA, qnrB, or qnrC, were not detected. Three MDRAB isolates that only carried armA16SrRNA methylase genes were resistant to amikacin, tobramycin, and gentamicin. Two isolates that did not carry AMES or 16SrRNA methylase were sensitive to amikacin, tobramycin, and gentamicin.
Analysis of the clinical data
A total of 44 isolates collected from sputum samples of patients carried MDRAB. These patients had symptoms of respiratory tract infection. MDRAB were detected in both sputum samples and thoracentesis fluid from 1 patient. MDRAB was detected in the fluid drained from one patient' after surgery. All patients with MDRAB 
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DISCUSSION
MDRAB has emerged as the most severe nosocomial pathogens . A previous study has reported that suction devicesand ventilator, as well as air conditioning, andtransfusion systems can be contaminated with this pathogen, spreading, MDRAB to patients (Shen and Ou, 2008) . A. baumannii is the most common opportunistic pathogen that causes respiratory tract infection. Among the 46 MDRAB isolates from our hospital, 44 isolates were collected from sputum samples of patients carrying MSRAB. All of the 44 patients exhibited symptoms of respiratory tract infection. Carbapenemases are β-lactamases with various hydrolytic capacities. Carbapenemases are members of molecular classes A, B, and D β-lactamases. KPC carbapenemases are the most prevalent in the class A carapenemase group. Class B enzymes include metallo-β-lactamases which contain zinc in the active site and belong to the IMP, VIM, SPM, CIM, and SIM families. These enzymes have been detected primarily in Pseudomonas aeruginosa. The class D carbapenemases consist of OXA-type β-lactamases. OXA-23, which can hydrolyze carbopenems antibiotics, is one of main factors that caused the multi-drug resistance of A. baumannii (Zou et al., 2010; Yu et al., 2011) . The OXA enzyme is the major product of A. baumannii. Several strains of A. baumannii also produce extended-spectrum β-lactamase, cephalosporinase, and metal enzyme, which can result in resistance to β-lactam antimicrobial agents. For example, IMP-4 mental enzymecan hydrolyze β-lactam antibiotics, including carbopenem and cephalosporin antibiotics. In addition, PRE-1 Extended-spectrum β-lactam enzyme can hydrolyze cephalosporin antibiotics. Our study shows that 41 isolates carried the OXA23gene (89.1%), 17 (37%)) the PER gene, and 6 (13%) carried the IMP gene. The sequence analysis of the PCR amplification products of three OXA23 gene positive isolates showed that they were all OXA-23 gene. The sequence analysis of the PCR amplification products of four PER gene positive isolates showed that they were all PER-1 gene. The results showed that OXA-23 is the most common carbapenemases gene among the MDRAB isolates collected from our hospital. This phenomenon is similar to the results of Ma et al. (2011) in which the OXA-type enzyme carbapenemase was found to have an important function in imipenem resistance of A. baumannii and the OXA-23 type enzyme is common in China. In addition, PER-1 and IMP-4 mental enzymes may be related to the β-lactam antibiotic resistance of MDRAB in our hospital. Galimand et al. (2000) reported that resistance to aminoglycoside antibiotics was caused by actions of aminoglycoside-modifying enzyme (AME) and mutations in the 16SrRNA genes of aminoglycoside antibiotics'. AMEs can be divided into acetyltransferase, phosphotransferase, and nucleoside transferase according to the different functions of the enzymes. More than 30 AME enzymes had been found (Chang et al., 2004) . A total of 46 MDRAB isolates were found in our study, of which 41 isolates carried ant (of which enaac(3)-I gene, 2 carried aac(3)-II gene, 1 carried aac(6c(6I gene, 1 carried aac (6aph(3h(3I gene, 1 carried aac(6c(6 gene, 1 was 89.1%, indicating that the resistance of MDRAB in our hospital to animoglycoside drug is related with AMEs. The positive rate of armA 16SrRNA was 87% (40/46), which is higher than the positive rate of 69.77% in 43 isolates of A. baumannii resistant to amilacin reported by Miao et al. (2011 ). Feng et al. (2008 have reported that the 16S rRNA methylase armA and rmtB genes were not detected in 20 MDRAB isolated. 16S rRNA methylase may have an important role in the resistance of MDRAB to aminoglycoside antibiotics in our hospital. In the current study, three MDRAB isolates that only carry the armA 16SrRNA methylase gene were resistant to amikacin, tobramycin, and gentamicin. Thus, armA 16SrRNA methylase gene may lead to resistance to aminoglycoside antibiotics alone. One isolate of MDRAB that only carry AMEs was sensitive to amikacin and tobramycin and was intermediary resistant to gentamicin. Two MDRAB isolates without AMEs or 16SrRNA methylase gene were all sensitive to amikacin, tobramycin, and gentamicin. These results indicate that AMEs and 16SrRNA methylase gene were related with the resistance of MDRAB' to aminoglycoside antibiotics. The positive rate of qacE∆1 in our hospital was 93.5% (43/46). The high resistance to disinfectants may be an important factor of nosocomial infection, which should be addressed by the disinfection department in our hospital.
The existence of plasmid-mediated fluoroquinolone resistance gene in MDRAB has been reported in several cities in China. The qnr gene positive rate was 43.9% in 57 isolates of Klebsiella pneumoniae producing extended -spectrum β-lactamase. Although the qnr gene was mainly detected from Enterobacter sp, Yang et al. (2009) reported that 2 of the 115 A. baumannii isolates were qnrB gene-positive. No plasmid-mediated quinolone fluoroquinolone resistance gene was detected from the 46 MDRAB isolates in our hospital, so MDRAB resistance to fluoroquinolones was not related to the plasmid-mediated fluoroquinolone resistance gene.
Among the 46 patients with MDRAB, 45 patients had symptoms of respiratory tract infection. The 46 patients used broad-spectrum antimicrobial drugs and were suffering from a variety of acute and (or) chronic diseases. Among the nine patients infected by MDRAB strain A, four patients were cured, three patients improved, and aba044  aba034  aba020  aba046  aba038  aba036  aba045  aba011  aba018  aba041  aba035  aba003  aba017  aba031  aba015  aba027  aba032  aba047  aba023  aba024  aba009  aba014  aba010  aba022  aba021  aba001/#1  aba016  aba028  aba037  aba053  aba005  aba007  aba004  aba049  aba025  aba029  aba033  aba039  aba040  aba019  aba054  aba013  aba006  aba050 two patients died. Analytical results show that several infected patients were related to nosocomial infections. However, the clinical effect was related to the patients' physical condition and the proper use of antibacterial drugs. A total of 44 isolates were collected from the sputum samples of patients with MDRAB. Although they were all qualified specimens, distinguishing infectious bacteria from bacterial colonization was difficult. Therefore, clinicians should improve the submission rate of blood culture. Table 4 shows that nine isolates of MDRAB strain A distributed in four intensive care units in our hospital were mainly derived from ICU 1. Eight isolates of MDRAB strain B were distributed in two intensive care units, seven came from ICU 2, and four isolates of MDRAB strain O were distributed in three intensive care units. Therefore, the common MDRAB stains in our hospital were mainly strains A and B, followed by strain O. Some of the patients infected by MDRAB strain A or B were transferred from other hospitals, so strains A and B may be the major epidemic MDRAB strains in this area.
In our study, the resistance rate of MDRAB to gentamicin, tobramycin, and amilacin were 93%. Two isolates exhibited intermediary resistance to levofloxacin. All the isolates were resistant to ciprofloxacin, ceftazidime, ceftriaxone, ciprofloxacin, cefepime, imipene, meropenem, piperacillin, and piperacillin/tazobactam. They also exhibited high sensitivity to tigecycline (60.9%) and minocycline (54.3%). The resistance rate to cefoperazone/sulbactam was 54%, and the intermediary resistance rates to cefoperazone/sulbactam were 32%. One of the isolates was sensitive to cotrimoxazole. None of the isolates was resistant to polymyxin E. Therefore, treatments of choice for MDRAB infection in our hospital are polymyxin + cefoperazone/sulbactam; and cefoperazone/sulbactam + minocycline or cefoperazone / sulbactam+ tigecycline.
Attention should be paid when clinicians select treatments for MDRAB infections because optional antibiotics for MDRAB are very limited. Clinicians should be aware of the characteristics of MDRAB in the area and strengthen the awareness of drug combination. Moreover, rational use of drug and prevention of the spread of resistant bacterium are important factors for controlling MDRAB in our hospital.
